Enveric Biosciences, Inc. (ENVB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 37.24K | 39.48K | 40.37K | 39.98K | 81.02K | 82.49K | 84.81K | 84.78K | 85.41K | 84.68K | 95.84K | 114.37K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -37.24K | -39.48K | -40.37K | -39.98K | -81.02K | -82.49K | -84.81K | -84.78K | -85.41K | -84.68K | -95.84K | -114.37K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 54.04% | 52.13% | 52.4% | 52.84% | 5.13% | 2.59% | 11.5% | 25.88% | 24.64% | 6.35% | 20.86% | -33.77% |
| Operating Expenses | 1.6M | 2.15M | 1.83M | 2.48M | 2.11M | 3.09M | 2M | 1.81M | 2.39M | 2.3M | 3.35M | 5.64M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.25M | 1.78M | 1.43M | 1.22M | 1.36M | 1.99M | 1.24M | 1.3M | 1.93M | 930.68K | 2M | 3.13M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 345.97K | 372.18K | 402.42K | 1.26M | 746.37K | 1.1M | 762.72K | 515.5K | 458.15K | 1.37M | 1.35M | 2.51M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M | -3.17M | -2.08M | -1.9M | -2.48M | -2.38M | -3.45M | -5.76M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 25.34% | 30.87% | 10.04% | -32.73% | 11.7% | -33.11% | 39.59% | 67.02% | 49.03% | 50.35% | 39.04% | -22.27% |
| EBITDA | -1.6M | -2.15M | -1.83M | -2.48M | -2.11M | -3.09M | -2M | -1.81M | -2.39M | -2.3M | -3.35M | -5.64M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 24.24% | 30.31% | 8.25% | -36.73% | 11.93% | -34.42% | 40.39% | 67.86% | 49.62% | 51.19% | 39.44% | -22.06% |
| D&A (Non-Cash Add-back) | 37.24K | 39.48K | 40.37K | 39.98K | 81.02K | 82.49K | 84.81K | 84.78K | 85.41K | 84.68K | 95.84K | 114.37K |
| EBIT | -1.63M | -2.19M | -1.87M | -2.52M | -2.18M | -3.15M | -2.08M | -1.88M | -2.48M | -3.41M | -2.82M | -6.36M |
| Net Interest Income | -303 | -250 | 274 | -132 | 0 | -225 | 0 | -35 | 696 | 566 | 2.24K | 916 |
| Interest Income | 0 | 0 | 274 | 0 | 0 | -225 | 0 | 0 | 696 | 566 | 2.24K | 916 |
| Interest Expense | 303 | 250 | 0 | 132 | 0 | 0 | 0 | 35 | - | 0 | 0 | 0 |
| Other Income/Expense | -303 | -248 | 274 | -132 | 2.57K | 26.38K | -840 | 18.54K | 22.13K | -1.03M | 632.77K | -601.05K |
| Pretax Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.18M | -3.15M | -2.08M | -1.88M | -2.46M | -3.41M | -2.82M | -6.36M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 7.2K | 0 | 0 | 1.73K | 22.32K | 6.59K | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0.23% | 0% | 0% | -0.07% | -0.65% | -0.23% | 0% |
| Net Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.18M | -3.15M | -2.08M | -1.88M | -2.46M | -3.44M | -2.82M | -6.36M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 25.24% | 30.45% | 10.09% | -34.04% | 11.07% | 8.19% | 26.16% | 70.46% | 47.61% | 60.46% | -13.27% | -127.38% |
| Net Income (Continuing) | -1.63M | -2.19M | -1.87M | -2.52M | -2.18M | -3.15M | -2.08M | -1.88M | -2.46M | -3.44M | -2.82M | -6.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08 | -3.81 | -10.81 | -11.64 | -14584.44 | -57.84 | -17.76 | -16.08 | -21.00 | -33.51 | -27.53 | -62.42 |
| EPS Growth % | 99.99% | 93.41% | 39.13% | 27.61% | -69349.71% | -72.61% | 35.49% | 74.24% | 55.15% | 60.96% | -703.73% | -519.25% |
| EPS (Basic) | -1.08 | -3.81 | -10.81 | -11.64 | -14584.44 | -69.84 | -43.08 | -9.84 | -7.32 | -17.52 | -15.60 | -36.24 |
| Diluted Shares Outstanding | 1.51M | 1.06M | 313.24K | 216.31K | 150 | 54.58K | 117.25K | 117.25K | 117.25K | 102.53K | 102.53K | 102.53K |
| Basic Shares Outstanding | 1.51M | 1.06M | 313.24K | 216.31K | 150 | 41.91K | 48.35K | 190.9K | 333.45K | 149.22K | 149.22K | 149.22K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |